Hoth Therapeutics Inc. (HOTH)
NASDAQ: HOTH
· Real-Time Price · USD
1.28
-0.01 (-0.78%)
At close: Aug 15, 2025, 3:59 PM
1.32
3.12%
After-hours: Aug 15, 2025, 07:39 PM EDT
Hoth Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 59.54K | 59.54K | 59.54K | 59.54K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 4.35K | 4.35K | n/a | 29.77K | 36.52K | 44.42K | 59.54K | 96.6K | 107.48K | 115.17K | 113.95K | 46.92M | 46.91M | 46.91M | 46.9M | 58.51K | 59.73K | 43.43K |
Gross Profit | -4.35K | -4.35K | n/a | 29.77K | 23.02K | 15.12K | n/a | -96.6K | -107.48K | -115.17K | -113.95K | -46.92M | -46.91M | -46.91M | -46.9M | -58.51K | -59.73K | -43.43K |
Operating Income | -10.19M | -9.64M | -8.22M | -7.53M | -7.49M | -7.55M | -7.69M | -9.42M | -10.01M | -10.6M | -11.07M | -11.02M | -11.59M | -12.49M | -14.1M | -11.52M | -10.44M | -9.75M |
Interest Income | n/a | n/a | n/a | 751.34 | 51.74K | 51.74K | 51.77K | 57.39K | 6.4K | 6.4K | 6.37K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -10.19M | -9.62M | -8.19M | -7.51M | -7.46M | -7.7M | -7.85M | -9.62M | -10.18M | -10.98M | -11.37M | -11.37M | -12.03M | -12.62M | -14.31M | -11.59M | -10.41M | -9.63M |
Net Income | -10.19M | -9.62M | -8.19M | -7.51M | -7.46M | -7.7M | -7.84M | -9.96M | -10.48M | -11.28M | -11.59M | -11.24M | -11.94M | -12.53M | -14.31M | -11.59M | -10.41M | -9.63M |
Selling & General & Admin | 4.98M | 4.9M | 4.97M | 4.69M | 4.57M | 4.55M | 4.21M | 5.38M | 5.48M | 5.72M | 5.92M | 5.39M | 5.26M | 5.17M | 6.17M | 5.29M | 5.49M | 5.44M |
Research & Development | 5.22M | 4.74M | 3.25M | 2.84M | 2.92M | 3.01M | 3.48M | 4.03M | 4.52M | 4.88M | 4.93M | 5.42M | 6.12M | 6.89M | 7.53M | 5.74M | 4.33M | 3.83M |
Other Expenses | n/a | n/a | 105.75K | 105.75K | 105.75K | 105.75K | n/a | 410.31K | 409.72K | 409.45K | 622.13K | 111.84K | 112.44K | 35.84K | -169.41K | -23.34K | 26.56K | 121.71K |
Operating Expenses | 10.19M | 9.64M | 8.32M | 7.64M | 7.6M | 7.66M | 7.69M | 9.42M | 10.01M | 10.6M | 11.07M | 11.02M | 11.59M | 12.49M | 14.1M | 11.52M | 10.44M | 9.75M |
Interest Expense | n/a | n/a | n/a | 9.31K | 9.31K | 9.31K | 9.31K | 345.59K | 345.59K | 345.59K | 345.59K | 99.98K | 99.98K | 99.98K | 99.98K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.19M | 9.64M | 8.22M | 7.53M | 7.49M | 7.55M | 7.69M | 9.42M | 10.01M | 10.6M | 11.07M | 11.02M | 11.59M | 12.49M | 14.1M | 11.52M | 10.44M | 9.75M |
Income Tax Expense | n/a | n/a | n/a | -1.7K | -1.7K | -1.7K | -11.01K | 336.28K | 296.1K | 296.1K | 216.22K | -129.37K | -89.45K | -89.71K | -783 | -783 | -522 | -261 |
Shares Outstanding (Basic) | 13.18M | 127.28K | 7.29M | 6.9M | 6.88M | 4.4M | 4.35M | 3.48M | 3.3M | 2.48M | 1.2M | 1.29M | 1.24M | 958.99K | 893.23K | 955.51K | 947.78K | 707.1K |
Shares Outstanding (Diluted) | 13.18M | 127.28K | 7.29M | 6.9M | 6.88M | 4.4M | 4.35M | 3.48M | 3.3M | 2.48M | 1.2M | 1.29M | 1.24M | 958.99K | 893.23K | 955.54K | 947.78K | 707.1K |
EPS (Basic) | -28.12 | -28.19 | -1.34 | -1.4 | -1.69 | -2.02 | -2.44 | -5.24 | -6.66 | -8.25 | -9.96 | -10.67 | -12.1 | -13.4 | -16.84 | -14.47 | -14.96 | -16.57 |
EPS (Diluted) | -28.12 | -28.19 | -1.34 | -1.4 | -1.69 | -2.02 | -2.44 | -5.24 | -6.66 | -8.25 | -9.96 | -10.67 | -12.1 | -13.4 | -16.84 | -14.47 | -14.96 | -16.57 |
EBITDA | -10.19M | -9.64M | -6.16M | -5.48M | -5.44M | -5.34M | -7.53M | -9.06M | -9.65M | -10.05M | -10.52M | -10.67M | -11.24M | -12.49M | -14.1M | -11.52M | -10.44M | -9.75M |
EBIT | -10.19M | -9.64M | -8.22M | -7.53M | -7.49M | -7.55M | -7.69M | -9.42M | -10.01M | -10.6M | -11.07M | -11.02M | -11.59M | -12.49M | -14.1M | -11.52M | -10.44M | -9.75M |
Depreciation & Amortization | 4.35K | 4.35K | 2.05M | 3.75M | 5.84M | 7.55M | 7.69M | 9.42M | 10.01M | 10.6M | 11.07M | 7.64M | 4.96M | 2.66M | 1.04K | 907.00 | 955.00 | 999.00 |